The cell and gene therapy industry is rapidly evolving, transitioning toward sourcing isolated cell populations as starting material, rather than heterogeneous raw materials. Isolated cells are a sought-after starting material that saves developers valuable time and resources, allowing a deeper dive into their research and accelerating their studies.
In this case study, we highlight the benefits of working with isolated cells as starting material for the development of effective cellular therapies, and address the following areas:
- Best practices in the isolation of cellular starting materials
- Working with isolated cell types to ensure purity and decrease interference from other cell types, so that the functions and responses of only the targeted cell population can be effectively examined
- Enablement of detailed genetic and phenotypic research into specific cell types, while increasing the sensitivity of functional assays and other analytical methods
- Cryopreservation as a key benefit to maintaining viability and function over long-term storage and long-distance shipping, safeguarding both consistency and availability
Have questions for our scientists or want more information?
Ask an Expert